News

In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in genetic analysis, molecular biology and cell science, we now know more about the human condition than ever before. This wealth of information opens the door for the next revolution in medicine – treatments that are truly tailored for each patient....

Concern over the lack of significant minority participation by patients in clinical trials has waxed and waned over the past 30 years. Now, there is growing momentum in favor if boosting the numbers—and it's about time, because minority patients can no longer wait. ...

Illumina, Inc., which has a Madison affiliate, Epicentre, announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array. This new array was developed for and inspired by the All of Us Research Program. All of Us is an historic effort to gather data from one million or more people living in the United States, to accelerate human disease research and improve health. ...